{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T21:37:21Z","timestamp":1766612241344},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,15]]},"DOI":"10.7759\/cureus.26892","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T16:22:37Z","timestamp":1657902157000},"source":"Crossref","is-referenced-by-count":1,"title":["Embolic Cerebrovascular Accident Secondary to Device-Related Thrombus Post WATCHMAN Device Implantation"],"prefix":"10.7759","author":[{"given":"Palak","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagapratap","family":"Ganta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Filice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Richard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick","family":"Acquah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"Alnabwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harshil  B","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/1747493019897870","article-title":"Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge","volume":"16","author":"Lippi G","year":"2021","unstructured":"Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J Stroke. 2021, 16:217-21. 10.1177\/1747493019897870","journal-title":"Int J Stroke"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/1747493018765491","article-title":"Impact of atrial fibrillation on inpatient cost for ischemic stroke in the USA","volume":"14","author":"Mukherjee K","year":"2019","unstructured":"Mukherjee K, Kamal KM. Impact of atrial fibrillation on inpatient cost for ischemic stroke in the USA. Int J Stroke. 2019, 14:159-66. 10.1177\/1747493018765491","journal-title":"Int J Stroke"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association","volume":"33","author":"Camm AJ","year":"2012","unstructured":"Camm AJ, Lip GY, De Caterina R, et al.. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012, 33:2719-47. 10.1093\/eurheartj\/ehs253","journal-title":"Eur Heart J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/VHRM.S187656","article-title":"When to withhold oral anticoagulation in atrial fibrillation - an overview of frequent clinical discussion topics","volume":"15","author":"Seelig J","year":"2019","unstructured":"Seelig J, Pisters R, Hemels ME, Huisman MV, Ten Cate H, Alings M. When to withhold oral anticoagulation in atrial fibrillation - an overview of frequent clinical discussion topics. Vasc Health Risk Manag. 2019, 15:399-408. 10.2147\/VHRM.S187656","journal-title":"Vasc Health Risk Manag"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/17434440.2020.1781615","article-title":"The WATCHMAN left atrial appendage closure device for patients with atrial fibrillation: current status and future perspectives","volume":"17","author":"Wintgens LI","year":"2020","unstructured":"Wintgens LI, Maarse M, Swaans MJ, Rensing BJ, Van Dijk VF, Boersma LV. The WATCHMAN left atrial appendage closure device for patients with atrial fibrillation: current status and future perspectives. Expert Rev Med Devices. 2020, 17:615-26. 10.1080\/17434440.2020.1781615","journal-title":"Expert Rev Med Devices"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.035090","article-title":"Device-related thrombus after left atrial appendage closure: incidence, predictors, and outcomes","volume":"138","author":"Dukkipati SR","year":"2018","unstructured":"Dukkipati SR, Kar S, Holmes DR, et al.. Device-related thrombus after left atrial appendage closure: incidence, predictors, and outcomes. Circulation. 2018, 138:874-85. 10.1161\/CIRCULATIONAHA.118.035090","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes DR Jr","year":"2014","unstructured":"Holmes DR Jr, Kar S, Price MJ, et al.. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014, 64:1-12. 10.1016\/j.jacc.2014.04.029","journal-title":"J Am Coll Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5761\/atcs.ra.18-00014","article-title":"The efficacy and safety of the Watchman device in LAA occlusion in patients with non-valvular atrial fibrillation contraindicated to oral anticoagulation: a focused review","volume":"24","author":"Majule DN","year":"2018","unstructured":"Majule DN, Jing C, Rutahoile WM, Shonyela FS. The efficacy and safety of the Watchman device in LAA occlusion in patients with non-valvular atrial fibrillation contraindicated to oral anticoagulation: a focused review. Ann Thorac Cardiovasc Surg. 2018, 24:271-8. 10.5761\/atcs.ra.18-00014","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.01.044","article-title":"Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score","volume":"65","author":"Lip GY","year":"2015","unstructured":"Lip GY, Skj\u00f8th F, Rasmussen LH, Larsen TB. Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score. J Am Coll Cardiol. 2015, 65:1385-94. 10.1016\/j.jacc.2015.01.044","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.2011.02216.x","article-title":"Intraprocedural and long-term incomplete occlusion of the left atrial appendage following placement of the WATCHMAN device: a single center experience","volume":"23","author":"Bai R","year":"2012","unstructured":"Bai R, Horton RP, Di Biase L, et al.. Intraprocedural and long-term incomplete occlusion of the left atrial appendage following placement of the WATCHMAN device: a single center experience. J Cardiovasc Electrophysiol. 2012, 23:455-61. 10.1111\/j.1540-8167.2011.02216.x","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/pace.13796","article-title":"A comparison of postprocedural anticoagulation in high-risk patients undergoing WATCHMAN device implantation","volume":"42","author":"Cohen JA","year":"2019","unstructured":"Cohen JA, Heist EK, Galvin J, et al.. A comparison of postprocedural anticoagulation in high-risk patients undergoing WATCHMAN device implantation. Pacing Clin Electrophysiol. 2019, 42:1304-9. 10.1111\/pace.13796","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.01.076","article-title":"Device-related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation","volume":"71","author":"Fauchier L","year":"2018","unstructured":"Fauchier L, Cinaud A, Brigadeau F, et al.. Device-related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation. J Am Coll Cardiol. 2018, 71:1528-36. 10.1016\/j.jacc.2018.01.076","journal-title":"J Am Coll Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.04.098","article-title":"Predictors of device-related thrombus following percutaneous left atrial appendage occlusion","volume":"78","author":"Simard T","year":"2021","unstructured":"Simard T, Jung RG, Lehenbauer K, et al.. Predictors of device-related thrombus following percutaneous left atrial appendage occlusion. J Am Coll Cardiol. 2021, 78:297-313. 10.1016\/j.jacc.2021.04.098","journal-title":"J Am Coll Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.035764","article-title":"Left atrial appendage closure: two steps forward, one step back","volume":"138","author":"Ellis CR","year":"2018","unstructured":"Ellis CR, Piccini JP. Left atrial appendage closure: two steps forward, one step back. Circulation. 2018, 138:886-8. 10.1161\/CIRCULATIONAHA.118.035764","journal-title":"Circulation"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0000000000001064","article-title":"Diagnosis and treatment of intracardiac thrombus","volume":"78","author":"Patel M","year":"2021","unstructured":"Patel M, Wei X, Weigel K, Gertz ZM, Kron J, Robinson AA, Trankle CR. Diagnosis and treatment of intracardiac thrombus. J Cardiovasc Pharmacol. 2021, 78:361-71. 10.1097\/FJC.0000000000001064","journal-title":"J Cardiovasc Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/91692-embolic-cerebrovascular-accident-secondary-to-device-related-thrombus-post-watchman-device-implantation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:45:29Z","timestamp":1707507929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/91692-embolic-cerebrovascular-accident-secondary-to-device-related-thrombus-post-watchman-device-implantation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,15]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.26892","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,15]]}}}